Diffuse large B-cell lymphoma (DLBCL) is an aggressive blood cancer that kills most untreated patients within one year. Standard CHOP chemotherapy improves five-year survival to 70%—still a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback